nodes	percent_of_prediction	percent_of_DWPC	metapath
Pitavastatin—SLC10A1—Progesterone—uterine cancer	0.289	0.35	CbGbCtD
Pitavastatin—UGT2B7—Epirubicin—uterine cancer	0.0797	0.0965	CbGbCtD
Pitavastatin—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.053	0.0642	CbGbCtD
Pitavastatin—ABCG2—Dactinomycin—uterine cancer	0.0523	0.0634	CbGbCtD
Pitavastatin—ABCC2—Carboplatin—uterine cancer	0.0389	0.0471	CbGbCtD
Pitavastatin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.037	0.0448	CbGbCtD
Pitavastatin—ABCG2—Carboplatin—uterine cancer	0.0352	0.0426	CbGbCtD
Pitavastatin—CYP2C8—Progesterone—uterine cancer	0.0351	0.0426	CbGbCtD
Pitavastatin—ABCC2—Etoposide—uterine cancer	0.0327	0.0395	CbGbCtD
Pitavastatin—ABCG2—Etoposide—uterine cancer	0.0295	0.0358	CbGbCtD
Pitavastatin—CYP2C9—Progesterone—uterine cancer	0.0245	0.0297	CbGbCtD
Pitavastatin—ABCB1—Progesterone—uterine cancer	0.0238	0.0288	CbGbCtD
Pitavastatin—ABCC2—Doxorubicin—uterine cancer	0.0223	0.027	CbGbCtD
Pitavastatin—ABCG2—Doxorubicin—uterine cancer	0.0201	0.0244	CbGbCtD
Pitavastatin—ABCB1—Dactinomycin—uterine cancer	0.0189	0.0228	CbGbCtD
Pitavastatin—CYP2C8—Etoposide—uterine cancer	0.0157	0.019	CbGbCtD
Pitavastatin—ABCB1—Etoposide—uterine cancer	0.0106	0.0129	CbGbCtD
Pitavastatin—Forgetfulness—Progesterone—uterine cancer	0.00937	0.0934	CcSEcCtD
Pitavastatin—ABCB1—Doxorubicin—uterine cancer	0.00726	0.00879	CbGbCtD
Pitavastatin—Memory loss—Medroxyprogesterone Acetate—uterine cancer	0.00605	0.0603	CcSEcCtD
Pitavastatin—Myopathy—Progesterone—uterine cancer	0.0028	0.0279	CcSEcCtD
Pitavastatin—Memory impairment—Progesterone—uterine cancer	0.0025	0.0249	CcSEcCtD
Pitavastatin—SLC10A1—renal system—uterine cancer	0.00183	0.0383	CbGeAlD
Pitavastatin—HMGCR—myometrium—uterine cancer	0.00174	0.0364	CbGeAlD
Pitavastatin—UGT2B7—renal system—uterine cancer	0.00171	0.0359	CbGeAlD
Pitavastatin—Hepatic failure—Progesterone—uterine cancer	0.00159	0.0158	CcSEcCtD
Pitavastatin—SLCO1B3—vagina—uterine cancer	0.00152	0.0318	CbGeAlD
Pitavastatin—SLC10A1—female reproductive system—uterine cancer	0.00146	0.0307	CbGeAlD
Pitavastatin—Hepatic failure—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.0143	CcSEcCtD
Pitavastatin—Pain in extremity—Progesterone—uterine cancer	0.00143	0.0142	CcSEcCtD
Pitavastatin—Interstitial lung disease—Etoposide—uterine cancer	0.00142	0.0141	CcSEcCtD
Pitavastatin—Amnesia—Medroxyprogesterone Acetate—uterine cancer	0.00137	0.0137	CcSEcCtD
Pitavastatin—UGT2B7—female reproductive system—uterine cancer	0.00137	0.0288	CbGeAlD
Pitavastatin—HMGCR—epithelium—uterine cancer	0.00136	0.0286	CbGeAlD
Pitavastatin—HMGCR—uterine cervix—uterine cancer	0.00135	0.0283	CbGeAlD
Pitavastatin—HMGCR—smooth muscle tissue—uterine cancer	0.00131	0.0275	CbGeAlD
Pitavastatin—Pain in extremity—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.0129	CcSEcCtD
Pitavastatin—HMGCR—decidua—uterine cancer	0.00129	0.027	CbGeAlD
Pitavastatin—Nasopharyngitis—Progesterone—uterine cancer	0.00127	0.0127	CcSEcCtD
Pitavastatin—HMGCR—renal system—uterine cancer	0.00126	0.0265	CbGeAlD
Pitavastatin—HMGCR—endometrium—uterine cancer	0.00122	0.0256	CbGeAlD
Pitavastatin—SLCO1B1—renal system—uterine cancer	0.00121	0.0254	CbGeAlD
Pitavastatin—HMGCR—mammalian vulva—uterine cancer	0.00118	0.0248	CbGeAlD
Pitavastatin—Abdominal discomfort—Progesterone—uterine cancer	0.00118	0.0118	CcSEcCtD
Pitavastatin—Nasopharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00115	0.0115	CcSEcCtD
Pitavastatin—Myositis—Epirubicin—uterine cancer	0.00115	0.0114	CcSEcCtD
Pitavastatin—HMGCR—uterus—uterine cancer	0.00113	0.0236	CbGeAlD
Pitavastatin—Hepatic failure—Dactinomycin—uterine cancer	0.00112	0.0112	CcSEcCtD
Pitavastatin—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00112	0.0111	CcSEcCtD
Pitavastatin—SLCO2B1—decidua—uterine cancer	0.00109	0.0229	CbGeAlD
Pitavastatin—ORM1—endometrium—uterine cancer	0.00108	0.0227	CbGeAlD
Pitavastatin—Jaundice—Progesterone—uterine cancer	0.00107	0.0107	CcSEcCtD
Pitavastatin—SLCO2B1—renal system—uterine cancer	0.00107	0.0225	CbGeAlD
Pitavastatin—Abdominal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.0107	CcSEcCtD
Pitavastatin—Myositis—Doxorubicin—uterine cancer	0.00106	0.0106	CcSEcCtD
Pitavastatin—HMGCR—female reproductive system—uterine cancer	0.00101	0.0212	CbGeAlD
Pitavastatin—Hepatitis—Progesterone—uterine cancer	0.000986	0.00983	CcSEcCtD
Pitavastatin—Jaundice—Medroxyprogesterone Acetate—uterine cancer	0.00097	0.00967	CcSEcCtD
Pitavastatin—SLCO1B1—female reproductive system—uterine cancer	0.000969	0.0203	CbGeAlD
Pitavastatin—SLCO2B1—uterus—uterine cancer	0.000953	0.02	CbGeAlD
Pitavastatin—HMGCR—female gonad—uterine cancer	0.000921	0.0193	CbGeAlD
Pitavastatin—ABCG2—myometrium—uterine cancer	0.000919	0.0193	CbGeAlD
Pitavastatin—ABCC2—renal system—uterine cancer	0.000917	0.0193	CbGeAlD
Pitavastatin—HMGCR—vagina—uterine cancer	0.000915	0.0192	CbGeAlD
Pitavastatin—ORM1—female reproductive system—uterine cancer	0.000894	0.0188	CbGeAlD
Pitavastatin—Hepatitis—Medroxyprogesterone Acetate—uterine cancer	0.000893	0.00891	CcSEcCtD
Pitavastatin—SLCO2B1—female reproductive system—uterine cancer	0.000857	0.018	CbGeAlD
Pitavastatin—Back pain—Progesterone—uterine cancer	0.00083	0.00828	CcSEcCtD
Pitavastatin—Muscle spasms—Progesterone—uterine cancer	0.000825	0.00823	CcSEcCtD
Pitavastatin—Ill-defined disorder—Progesterone—uterine cancer	0.000796	0.00794	CcSEcCtD
Pitavastatin—SLCO2B1—female gonad—uterine cancer	0.00078	0.0164	CbGeAlD
Pitavastatin—Malaise—Progesterone—uterine cancer	0.000774	0.00772	CcSEcCtD
Pitavastatin—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.000752	0.0075	CcSEcCtD
Pitavastatin—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000748	0.00745	CcSEcCtD
Pitavastatin—ABCC2—female reproductive system—uterine cancer	0.000735	0.0154	CbGeAlD
Pitavastatin—Myalgia—Progesterone—uterine cancer	0.000731	0.00728	CcSEcCtD
Pitavastatin—Arthralgia—Progesterone—uterine cancer	0.000731	0.00728	CcSEcCtD
Pitavastatin—Discomfort—Progesterone—uterine cancer	0.000722	0.0072	CcSEcCtD
Pitavastatin—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000722	0.00719	CcSEcCtD
Pitavastatin—ABCG2—uterine cervix—uterine cancer	0.000715	0.015	CbGeAlD
Pitavastatin—Confusional state—Progesterone—uterine cancer	0.000706	0.00704	CcSEcCtD
Pitavastatin—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000701	0.00699	CcSEcCtD
Pitavastatin—Hepatitis—Dactinomycin—uterine cancer	0.000697	0.00695	CcSEcCtD
Pitavastatin—CYP2C8—renal system—uterine cancer	0.000688	0.0144	CbGeAlD
Pitavastatin—ABCG2—decidua—uterine cancer	0.000681	0.0143	CbGeAlD
Pitavastatin—CYP2C8—endometrium—uterine cancer	0.000665	0.014	CbGeAlD
Pitavastatin—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.0066	CcSEcCtD
Pitavastatin—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.0066	CcSEcCtD
Pitavastatin—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000654	0.00652	CcSEcCtD
Pitavastatin—ABCG2—endometrium—uterine cancer	0.000647	0.0136	CbGeAlD
Pitavastatin—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00064	0.00638	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000638	0.00636	CcSEcCtD
Pitavastatin—Insomnia—Progesterone—uterine cancer	0.000633	0.00632	CcSEcCtD
Pitavastatin—ABCG2—mammalian vulva—uterine cancer	0.000626	0.0131	CbGeAlD
Pitavastatin—Dyspepsia—Progesterone—uterine cancer	0.000617	0.00615	CcSEcCtD
Pitavastatin—Fatigue—Progesterone—uterine cancer	0.000604	0.00602	CcSEcCtD
Pitavastatin—Constipation—Progesterone—uterine cancer	0.000599	0.00597	CcSEcCtD
Pitavastatin—ABCG2—uterus—uterine cancer	0.000596	0.0125	CbGeAlD
Pitavastatin—HMGCR—lymph node—uterine cancer	0.000592	0.0124	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000578	0.00577	CcSEcCtD
Pitavastatin—Feeling abnormal—Progesterone—uterine cancer	0.000577	0.00575	CcSEcCtD
Pitavastatin—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000574	0.00572	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Progesterone—uterine cancer	0.000573	0.00571	CcSEcCtD
Pitavastatin—Ill-defined disorder—Dactinomycin—uterine cancer	0.000563	0.00561	CcSEcCtD
Pitavastatin—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000559	0.00557	CcSEcCtD
Pitavastatin—Urticaria—Progesterone—uterine cancer	0.000556	0.00555	CcSEcCtD
Pitavastatin—Abdominal pain—Progesterone—uterine cancer	0.000554	0.00552	CcSEcCtD
Pitavastatin—CYP2C8—female reproductive system—uterine cancer	0.000551	0.0116	CbGeAlD
Pitavastatin—Jaundice—Etoposide—uterine cancer	0.000548	0.00546	CcSEcCtD
Pitavastatin—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000547	0.00546	CcSEcCtD
Pitavastatin—Malaise—Dactinomycin—uterine cancer	0.000547	0.00545	CcSEcCtD
Pitavastatin—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000543	0.00541	CcSEcCtD
Pitavastatin—ORM1—lymph node—uterine cancer	0.000523	0.011	CbGeAlD
Pitavastatin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.00521	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000519	0.00517	CcSEcCtD
Pitavastatin—Myalgia—Dactinomycin—uterine cancer	0.000516	0.00515	CcSEcCtD
Pitavastatin—Hypersensitivity—Progesterone—uterine cancer	0.000516	0.00515	CcSEcCtD
Pitavastatin—Discomfort—Dactinomycin—uterine cancer	0.00051	0.00509	CcSEcCtD
Pitavastatin—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000504	0.00503	CcSEcCtD
Pitavastatin—Asthenia—Progesterone—uterine cancer	0.000503	0.00501	CcSEcCtD
Pitavastatin—Hypoaesthesia—Etoposide—uterine cancer	0.000502	0.005	CcSEcCtD
Pitavastatin—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000502	0.005	CcSEcCtD
Pitavastatin—SLCO2B1—lymph node—uterine cancer	0.000501	0.0105	CbGeAlD
Pitavastatin—CYP2C8—vagina—uterine cancer	0.000498	0.0105	CbGeAlD
Pitavastatin—Pruritus—Progesterone—uterine cancer	0.000496	0.00494	CcSEcCtD
Pitavastatin—CYP2C9—female reproductive system—uterine cancer	0.00049	0.0103	CbGeAlD
Pitavastatin—ABCG2—female gonad—uterine cancer	0.000488	0.0102	CbGeAlD
Pitavastatin—ABCG2—vagina—uterine cancer	0.000485	0.0102	CbGeAlD
Pitavastatin—Diarrhoea—Progesterone—uterine cancer	0.000479	0.00478	CcSEcCtD
Pitavastatin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000468	0.00466	CcSEcCtD
Pitavastatin—Dizziness—Progesterone—uterine cancer	0.000463	0.00462	CcSEcCtD
Pitavastatin—ALB—lymph node—uterine cancer	0.000459	0.00963	CbGeAlD
Pitavastatin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000455	0.00454	CcSEcCtD
Pitavastatin—Hepatic failure—Epirubicin—uterine cancer	0.000455	0.00453	CcSEcCtD
Pitavastatin—ABCB1—myometrium—uterine cancer	0.000453	0.00951	CbGeAlD
Pitavastatin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000451	0.0045	CcSEcCtD
Pitavastatin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00448	CcSEcCtD
Pitavastatin—Renal failure acute—Epirubicin—uterine cancer	0.000443	0.00441	CcSEcCtD
Pitavastatin—Rash—Progesterone—uterine cancer	0.000442	0.0044	CcSEcCtD
Pitavastatin—Dermatitis—Progesterone—uterine cancer	0.000441	0.0044	CcSEcCtD
Pitavastatin—Headache—Progesterone—uterine cancer	0.000439	0.00437	CcSEcCtD
Pitavastatin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000434	0.00433	CcSEcCtD
Pitavastatin—ABCC2—lymph node—uterine cancer	0.00043	0.00902	CbGeAlD
Pitavastatin—Fatigue—Dactinomycin—uterine cancer	0.000427	0.00426	CcSEcCtD
Pitavastatin—Back pain—Etoposide—uterine cancer	0.000425	0.00423	CcSEcCtD
Pitavastatin—Muscle spasms—Etoposide—uterine cancer	0.000422	0.00421	CcSEcCtD
Pitavastatin—Hepatic failure—Doxorubicin—uterine cancer	0.000421	0.0042	CcSEcCtD
Pitavastatin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00042	0.00418	CcSEcCtD
Pitavastatin—Nausea—Progesterone—uterine cancer	0.000416	0.00415	CcSEcCtD
Pitavastatin—Renal failure acute—Doxorubicin—uterine cancer	0.00041	0.00408	CcSEcCtD
Pitavastatin—Pain in extremity—Epirubicin—uterine cancer	0.000409	0.00407	CcSEcCtD
Pitavastatin—Feeling abnormal—Dactinomycin—uterine cancer	0.000408	0.00407	CcSEcCtD
Pitavastatin—Ill-defined disorder—Etoposide—uterine cancer	0.000407	0.00406	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000405	0.00404	CcSEcCtD
Pitavastatin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0004	0.00399	CcSEcCtD
Pitavastatin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0004	0.00399	CcSEcCtD
Pitavastatin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000398	0.00396	CcSEcCtD
Pitavastatin—Malaise—Etoposide—uterine cancer	0.000396	0.00395	CcSEcCtD
Pitavastatin—Abdominal pain—Dactinomycin—uterine cancer	0.000391	0.0039	CcSEcCtD
Pitavastatin—Pain in extremity—Doxorubicin—uterine cancer	0.000378	0.00377	CcSEcCtD
Pitavastatin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000377	0.00376	CcSEcCtD
Pitavastatin—Discomfort—Etoposide—uterine cancer	0.000369	0.00368	CcSEcCtD
Pitavastatin—Nasopharyngitis—Epirubicin—uterine cancer	0.000365	0.00364	CcSEcCtD
Pitavastatin—Hypersensitivity—Dactinomycin—uterine cancer	0.000365	0.00364	CcSEcCtD
Pitavastatin—Confusional state—Etoposide—uterine cancer	0.000361	0.0036	CcSEcCtD
Pitavastatin—ABCB1—epithelium—uterine cancer	0.000356	0.00747	CbGeAlD
Pitavastatin—Asthenia—Dactinomycin—uterine cancer	0.000355	0.00354	CcSEcCtD
Pitavastatin—Influenza—Epirubicin—uterine cancer	0.000353	0.00352	CcSEcCtD
Pitavastatin—ABCB1—uterine cervix—uterine cancer	0.000353	0.0074	CbGeAlD
Pitavastatin—Diarrhoea—Dactinomycin—uterine cancer	0.000339	0.00338	CcSEcCtD
Pitavastatin—Nasopharyngitis—Doxorubicin—uterine cancer	0.000338	0.00337	CcSEcCtD
Pitavastatin—ABCB1—decidua—uterine cancer	0.000336	0.00705	CbGeAlD
Pitavastatin—ABCB1—renal system—uterine cancer	0.00033	0.00692	CbGeAlD
Pitavastatin—Influenza—Doxorubicin—uterine cancer	0.000327	0.00326	CcSEcCtD
Pitavastatin—ABCB1—endometrium—uterine cancer	0.000319	0.00669	CbGeAlD
Pitavastatin—ABCG2—lymph node—uterine cancer	0.000313	0.00658	CbGeAlD
Pitavastatin—Rash—Dactinomycin—uterine cancer	0.000312	0.00311	CcSEcCtD
Pitavastatin—Fatigue—Etoposide—uterine cancer	0.000309	0.00308	CcSEcCtD
Pitavastatin—ABCB1—mammalian vulva—uterine cancer	0.000309	0.00648	CbGeAlD
Pitavastatin—Jaundice—Epirubicin—uterine cancer	0.000307	0.00306	CcSEcCtD
Pitavastatin—Constipation—Etoposide—uterine cancer	0.000306	0.00305	CcSEcCtD
Pitavastatin—Feeling abnormal—Etoposide—uterine cancer	0.000295	0.00294	CcSEcCtD
Pitavastatin—Nausea—Dactinomycin—uterine cancer	0.000294	0.00293	CcSEcCtD
Pitavastatin—ABCB1—uterus—uterine cancer	0.000294	0.00617	CbGeAlD
Pitavastatin—Gastrointestinal pain—Etoposide—uterine cancer	0.000293	0.00292	CcSEcCtD
Pitavastatin—Urticaria—Etoposide—uterine cancer	0.000285	0.00284	CcSEcCtD
Pitavastatin—Jaundice—Doxorubicin—uterine cancer	0.000284	0.00283	CcSEcCtD
Pitavastatin—Abdominal pain—Etoposide—uterine cancer	0.000283	0.00282	CcSEcCtD
Pitavastatin—Hepatitis—Epirubicin—uterine cancer	0.000283	0.00282	CcSEcCtD
Pitavastatin—Hypoaesthesia—Epirubicin—uterine cancer	0.000281	0.0028	CcSEcCtD
Pitavastatin—ABCB1—female reproductive system—uterine cancer	0.000264	0.00555	CbGeAlD
Pitavastatin—Hypersensitivity—Etoposide—uterine cancer	0.000264	0.00263	CcSEcCtD
Pitavastatin—Hepatitis—Doxorubicin—uterine cancer	0.000262	0.00261	CcSEcCtD
Pitavastatin—Hypoaesthesia—Doxorubicin—uterine cancer	0.00026	0.00259	CcSEcCtD
Pitavastatin—Asthenia—Etoposide—uterine cancer	0.000257	0.00256	CcSEcCtD
Pitavastatin—Pruritus—Etoposide—uterine cancer	0.000253	0.00253	CcSEcCtD
Pitavastatin—Diarrhoea—Etoposide—uterine cancer	0.000245	0.00244	CcSEcCtD
Pitavastatin—ABCB1—female gonad—uterine cancer	0.00024	0.00505	CbGeAlD
Pitavastatin—ABCB1—vagina—uterine cancer	0.000239	0.00502	CbGeAlD
Pitavastatin—Back pain—Epirubicin—uterine cancer	0.000238	0.00237	CcSEcCtD
Pitavastatin—Dizziness—Etoposide—uterine cancer	0.000237	0.00236	CcSEcCtD
Pitavastatin—Muscle spasms—Epirubicin—uterine cancer	0.000237	0.00236	CcSEcCtD
Pitavastatin—Ill-defined disorder—Epirubicin—uterine cancer	0.000228	0.00228	CcSEcCtD
Pitavastatin—Rash—Etoposide—uterine cancer	0.000226	0.00225	CcSEcCtD
Pitavastatin—Dermatitis—Etoposide—uterine cancer	0.000226	0.00225	CcSEcCtD
Pitavastatin—Headache—Etoposide—uterine cancer	0.000224	0.00224	CcSEcCtD
Pitavastatin—Malaise—Epirubicin—uterine cancer	0.000222	0.00221	CcSEcCtD
Pitavastatin—Back pain—Doxorubicin—uterine cancer	0.00022	0.0022	CcSEcCtD
Pitavastatin—Muscle spasms—Doxorubicin—uterine cancer	0.000219	0.00218	CcSEcCtD
Pitavastatin—Nausea—Etoposide—uterine cancer	0.000213	0.00212	CcSEcCtD
Pitavastatin—Ill-defined disorder—Doxorubicin—uterine cancer	0.000211	0.00211	CcSEcCtD
Pitavastatin—Arthralgia—Epirubicin—uterine cancer	0.00021	0.00209	CcSEcCtD
Pitavastatin—Myalgia—Epirubicin—uterine cancer	0.00021	0.00209	CcSEcCtD
Pitavastatin—Discomfort—Epirubicin—uterine cancer	0.000207	0.00206	CcSEcCtD
Pitavastatin—Malaise—Doxorubicin—uterine cancer	0.000205	0.00205	CcSEcCtD
Pitavastatin—Confusional state—Epirubicin—uterine cancer	0.000203	0.00202	CcSEcCtD
Pitavastatin—Myalgia—Doxorubicin—uterine cancer	0.000194	0.00193	CcSEcCtD
Pitavastatin—Arthralgia—Doxorubicin—uterine cancer	0.000194	0.00193	CcSEcCtD
Pitavastatin—Discomfort—Doxorubicin—uterine cancer	0.000192	0.00191	CcSEcCtD
Pitavastatin—Confusional state—Doxorubicin—uterine cancer	0.000187	0.00187	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000183	0.00182	CcSEcCtD
Pitavastatin—Insomnia—Epirubicin—uterine cancer	0.000182	0.00181	CcSEcCtD
Pitavastatin—Dyspepsia—Epirubicin—uterine cancer	0.000177	0.00176	CcSEcCtD
Pitavastatin—Fatigue—Epirubicin—uterine cancer	0.000173	0.00173	CcSEcCtD
Pitavastatin—Constipation—Epirubicin—uterine cancer	0.000172	0.00171	CcSEcCtD
Pitavastatin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000169	0.00169	CcSEcCtD
Pitavastatin—Insomnia—Doxorubicin—uterine cancer	0.000168	0.00168	CcSEcCtD
Pitavastatin—Feeling abnormal—Epirubicin—uterine cancer	0.000165	0.00165	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000164	0.00164	CcSEcCtD
Pitavastatin—Dyspepsia—Doxorubicin—uterine cancer	0.000164	0.00163	CcSEcCtD
Pitavastatin—Fatigue—Doxorubicin—uterine cancer	0.00016	0.0016	CcSEcCtD
Pitavastatin—Urticaria—Epirubicin—uterine cancer	0.00016	0.00159	CcSEcCtD
Pitavastatin—Constipation—Doxorubicin—uterine cancer	0.000159	0.00158	CcSEcCtD
Pitavastatin—Abdominal pain—Epirubicin—uterine cancer	0.000159	0.00158	CcSEcCtD
Pitavastatin—ABCB1—lymph node—uterine cancer	0.000155	0.00324	CbGeAlD
Pitavastatin—Feeling abnormal—Doxorubicin—uterine cancer	0.000153	0.00153	CcSEcCtD
Pitavastatin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000152	0.00152	CcSEcCtD
Pitavastatin—Hypersensitivity—Epirubicin—uterine cancer	0.000148	0.00148	CcSEcCtD
Pitavastatin—Urticaria—Doxorubicin—uterine cancer	0.000148	0.00147	CcSEcCtD
Pitavastatin—Abdominal pain—Doxorubicin—uterine cancer	0.000147	0.00146	CcSEcCtD
Pitavastatin—Asthenia—Epirubicin—uterine cancer	0.000144	0.00144	CcSEcCtD
Pitavastatin—Pruritus—Epirubicin—uterine cancer	0.000142	0.00142	CcSEcCtD
Pitavastatin—Diarrhoea—Epirubicin—uterine cancer	0.000137	0.00137	CcSEcCtD
Pitavastatin—Hypersensitivity—Doxorubicin—uterine cancer	0.000137	0.00137	CcSEcCtD
Pitavastatin—Asthenia—Doxorubicin—uterine cancer	0.000133	0.00133	CcSEcCtD
Pitavastatin—Dizziness—Epirubicin—uterine cancer	0.000133	0.00132	CcSEcCtD
Pitavastatin—Pruritus—Doxorubicin—uterine cancer	0.000131	0.00131	CcSEcCtD
Pitavastatin—Diarrhoea—Doxorubicin—uterine cancer	0.000127	0.00127	CcSEcCtD
Pitavastatin—Rash—Epirubicin—uterine cancer	0.000127	0.00126	CcSEcCtD
Pitavastatin—Dermatitis—Epirubicin—uterine cancer	0.000127	0.00126	CcSEcCtD
Pitavastatin—Headache—Epirubicin—uterine cancer	0.000126	0.00125	CcSEcCtD
Pitavastatin—Dizziness—Doxorubicin—uterine cancer	0.000123	0.00123	CcSEcCtD
Pitavastatin—Nausea—Epirubicin—uterine cancer	0.000119	0.00119	CcSEcCtD
Pitavastatin—Rash—Doxorubicin—uterine cancer	0.000117	0.00117	CcSEcCtD
Pitavastatin—Dermatitis—Doxorubicin—uterine cancer	0.000117	0.00117	CcSEcCtD
Pitavastatin—Headache—Doxorubicin—uterine cancer	0.000116	0.00116	CcSEcCtD
Pitavastatin—Nausea—Doxorubicin—uterine cancer	0.00011	0.0011	CcSEcCtD
Pitavastatin—CYP2C8—Metapathway biotransformation—CYP19A1—uterine cancer	4.39e-05	0.00166	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	4.37e-05	0.00165	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKR1C1—uterine cancer	4.28e-05	0.00162	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP11A1—uterine cancer	4.28e-05	0.00162	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	4.23e-05	0.0016	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—SRD5A2—uterine cancer	4.16e-05	0.00157	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—NDUFB11—uterine cancer	4.16e-05	0.00157	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.04e-05	0.00153	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—STAR—uterine cancer	4.04e-05	0.00153	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKR1B1—uterine cancer	4.04e-05	0.00153	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKR1C3—uterine cancer	4.04e-05	0.00153	CbGpPWpGaD
Pitavastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—uterine cancer	4.01e-05	0.00152	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	3.92e-05	0.00149	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.88e-05	0.00147	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.88e-05	0.00147	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.86e-05	0.00146	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.86e-05	0.00146	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—NDUFB11—uterine cancer	3.85e-05	0.00146	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—SRD5A2—uterine cancer	3.85e-05	0.00146	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	3.82e-05	0.00144	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—RRM2—uterine cancer	3.81e-05	0.00144	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—POLD1—uterine cancer	3.73e-05	0.00141	CbGpPWpGaD
Pitavastatin—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	3.72e-05	0.00141	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—DCN—uterine cancer	3.7e-05	0.0014	CbGpPWpGaD
Pitavastatin—ALB—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.67e-05	0.00139	CbGpPWpGaD
Pitavastatin—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	3.62e-05	0.00137	CbGpPWpGaD
Pitavastatin—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	3.57e-05	0.00135	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	3.56e-05	0.00135	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—POLD1—uterine cancer	3.51e-05	0.00133	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKR1C1—uterine cancer	3.49e-05	0.00132	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP11A1—uterine cancer	3.49e-05	0.00132	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—CXCL8—uterine cancer	3.36e-05	0.00127	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—uterine cancer	3.32e-05	0.00126	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKR1C3—uterine cancer	3.29e-05	0.00125	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKR1C1—uterine cancer	3.29e-05	0.00124	CbGpPWpGaD
Pitavastatin—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	3.21e-05	0.00122	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	3.19e-05	0.00121	CbGpPWpGaD
Pitavastatin—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—uterine cancer	3.17e-05	0.0012	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—POLD1—uterine cancer	3.17e-05	0.0012	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	3.16e-05	0.0012	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	3.16e-05	0.0012	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	3.15e-05	0.00119	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—CYP19A1—uterine cancer	3.15e-05	0.00119	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—STK11—uterine cancer	3.15e-05	0.00119	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—RRM2—uterine cancer	3.11e-05	0.00118	CbGpPWpGaD
Pitavastatin—ALB—Platelet degranulation—VEGFA—uterine cancer	3.08e-05	0.00117	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—DCN—uterine cancer	3.02e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKR1B1—uterine cancer	3.01e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—STAR—uterine cancer	3.01e-05	0.00114	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	2.97e-05	0.00113	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKR1C1—uterine cancer	2.96e-05	0.00112	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.95e-05	0.00112	CbGpPWpGaD
Pitavastatin—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—uterine cancer	2.94e-05	0.00111	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—RRM2—uterine cancer	2.93e-05	0.00111	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.85e-05	0.00108	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—DCN—uterine cancer	2.84e-05	0.00108	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP11A1—uterine cancer	2.84e-05	0.00108	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.83e-05	0.00107	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.82e-05	0.00107	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKR1B1—uterine cancer	2.78e-05	0.00105	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—STAR—uterine cancer	2.78e-05	0.00105	CbGpPWpGaD
Pitavastatin—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.73e-05	0.00103	CbGpPWpGaD
Pitavastatin—ALB—Folate Metabolism—TP53—uterine cancer	2.72e-05	0.00103	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKR1C3—uterine cancer	2.68e-05	0.00102	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP11A1—uterine cancer	2.68e-05	0.00101	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—RRM2—uterine cancer	2.64e-05	0.001	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—STK11—uterine cancer	2.56e-05	0.000971	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—CYP19A1—uterine cancer	2.56e-05	0.000971	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—DCN—uterine cancer	2.56e-05	0.000971	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKR1C3—uterine cancer	2.53e-05	0.000957	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP11A1—uterine cancer	2.42e-05	0.000915	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.41e-05	0.000912	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.39e-05	0.000905	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.39e-05	0.000905	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—IRF1—uterine cancer	2.38e-05	0.000902	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.38e-05	0.000901	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—NDUFB11—uterine cancer	2.38e-05	0.0009	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—SRD5A2—uterine cancer	2.38e-05	0.0009	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—MTHFR—uterine cancer	2.36e-05	0.000895	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—POLD1—uterine cancer	2.36e-05	0.000893	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.32e-05	0.000879	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.32e-05	0.000878	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.31e-05	0.000874	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.3e-05	0.000869	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKR1C3—uterine cancer	2.28e-05	0.000864	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKR1C1—uterine cancer	2.21e-05	0.000836	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.19e-05	0.00083	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—POLD1—uterine cancer	2.19e-05	0.000827	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.18e-05	0.000825	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—STK11—uterine cancer	2.09e-05	0.000792	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—CYP19A1—uterine cancer	2.09e-05	0.000792	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.08e-05	0.000789	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—SRD5A2—uterine cancer	2.08e-05	0.000788	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—NDUFB11—uterine cancer	2.08e-05	0.000788	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKR1C1—uterine cancer	2.04e-05	0.000774	CbGpPWpGaD
Pitavastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	2.01e-05	0.000761	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—STK11—uterine cancer	1.97e-05	0.000746	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—CYP19A1—uterine cancer	1.97e-05	0.000746	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—RRM2—uterine cancer	1.97e-05	0.000745	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.95e-05	0.000736	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.95e-05	0.000736	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—MTHFR—uterine cancer	1.93e-05	0.00073	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—DCN—uterine cancer	1.91e-05	0.000723	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.89e-05	0.000715	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.85e-05	0.0007	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—RRM2—uterine cancer	1.82e-05	0.00069	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP11A1—uterine cancer	1.8e-05	0.000681	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.78e-05	0.000676	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—STK11—uterine cancer	1.78e-05	0.000673	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—CYP19A1—uterine cancer	1.78e-05	0.000673	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—DCN—uterine cancer	1.77e-05	0.00067	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.76e-05	0.000668	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.75e-05	0.000661	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.73e-05	0.000654	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—STAR—uterine cancer	1.73e-05	0.000654	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKR1B1—uterine cancer	1.72e-05	0.000651	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—STAR—uterine cancer	1.72e-05	0.000651	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.71e-05	0.000647	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKR1C3—uterine cancer	1.7e-05	0.000643	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.7e-05	0.000643	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.7e-05	0.000643	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP11A1—uterine cancer	1.67e-05	0.000631	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.62e-05	0.000613	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKR1C3—uterine cancer	1.57e-05	0.000596	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—MTHFR—uterine cancer	1.57e-05	0.000595	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.53e-05	0.000579	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKR1B1—uterine cancer	1.51e-05	0.00057	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—STAR—uterine cancer	1.51e-05	0.00057	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.49e-05	0.000564	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—MTHFR—uterine cancer	1.48e-05	0.000561	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.42e-05	0.000538	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—STAR—uterine cancer	1.41e-05	0.000532	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.41e-05	0.000532	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.39e-05	0.000526	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—VEGFA—uterine cancer	1.37e-05	0.000517	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—POLD1—uterine cancer	1.36e-05	0.000513	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—POLD1—uterine cancer	1.35e-05	0.00051	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.35e-05	0.000509	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—MTHFR—uterine cancer	1.34e-05	0.000506	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—STK11—uterine cancer	1.32e-05	0.000501	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—CYP19A1—uterine cancer	1.32e-05	0.000501	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PTEN—uterine cancer	1.32e-05	0.000498	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.3e-05	0.000494	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.27e-05	0.00048	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKR1C1—uterine cancer	1.26e-05	0.000477	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—EP300—uterine cancer	1.25e-05	0.000475	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.24e-05	0.00047	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—STK11—uterine cancer	1.23e-05	0.000464	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—CYP19A1—uterine cancer	1.23e-05	0.000464	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.19e-05	0.000449	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—POLD1—uterine cancer	1.18e-05	0.000447	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.14e-05	0.000433	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—RRM2—uterine cancer	1.13e-05	0.000428	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—RRM2—uterine cancer	1.12e-05	0.000426	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKR1C1—uterine cancer	1.11e-05	0.000418	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—POLD1—uterine cancer	1.1e-05	0.000418	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—DCN—uterine cancer	1.1e-05	0.000415	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—DCN—uterine cancer	1.09e-05	0.000413	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PTEN—uterine cancer	1.07e-05	0.000406	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—PIK3CA—uterine cancer	1.07e-05	0.000404	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.05e-05	0.000398	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000391	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKR1C1—uterine cancer	1.03e-05	0.000391	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP11A1—uterine cancer	1.03e-05	0.000389	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—EP300—uterine cancer	1.02e-05	0.000387	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.02e-05	0.000385	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—MTHFR—uterine cancer	9.95e-06	0.000377	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—RRM2—uterine cancer	9.85e-06	0.000373	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKR1C3—uterine cancer	9.76e-06	0.00037	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKR1C3—uterine cancer	9.71e-06	0.000368	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—DCN—uterine cancer	9.56e-06	0.000362	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—PIK3CA—uterine cancer	9.28e-06	0.000351	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—MTHFR—uterine cancer	9.21e-06	0.000349	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—RRM2—uterine cancer	9.2e-06	0.000348	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP11A1—uterine cancer	9.01e-06	0.000341	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—DCN—uterine cancer	8.93e-06	0.000338	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.77e-06	0.000332	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PTEN—uterine cancer	8.74e-06	0.000331	CbGpPWpGaD
Pitavastatin—ALB—Platelet activation, signaling and aggregation—AKT1—uterine cancer	8.72e-06	0.00033	CbGpPWpGaD
Pitavastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	8.59e-06	0.000325	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKR1C3—uterine cancer	8.51e-06	0.000322	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP11A1—uterine cancer	8.42e-06	0.000319	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—EP300—uterine cancer	8.34e-06	0.000316	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PTEN—uterine cancer	8.24e-06	0.000312	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.95e-06	0.000301	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—EP300—uterine cancer	7.86e-06	0.000297	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—STK11—uterine cancer	7.61e-06	0.000288	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—CYP19A1—uterine cancer	7.61e-06	0.000288	CbGpPWpGaD
Pitavastatin—SLC10A1—Metabolism—AKT1—uterine cancer	7.58e-06	0.000287	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—PIK3CA—uterine cancer	7.56e-06	0.000286	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—CYP19A1—uterine cancer	7.56e-06	0.000286	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—STK11—uterine cancer	7.56e-06	0.000286	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—EP300—uterine cancer	7.44e-06	0.000282	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PTEN—uterine cancer	7.43e-06	0.000281	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.14e-06	0.00027	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	7.1e-06	0.000269	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—EP300—uterine cancer	7.09e-06	0.000268	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—VEGFA—uterine cancer	7.04e-06	0.000267	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—NRAS—uterine cancer	6.96e-06	0.000263	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.81e-06	0.000258	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.77e-06	0.000256	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—STK11—uterine cancer	6.63e-06	0.000251	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—CYP19A1—uterine cancer	6.63e-06	0.000251	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—STK11—uterine cancer	6.19e-06	0.000234	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—CYP19A1—uterine cancer	6.19e-06	0.000234	CbGpPWpGaD
Pitavastatin—HMGCR—Metabolism—AKT1—uterine cancer	6.18e-06	0.000234	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—PIK3CA—uterine cancer	6.17e-06	0.000233	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—KRAS—uterine cancer	5.99e-06	0.000227	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.81e-06	0.00022	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—PIK3CA—uterine cancer	5.81e-06	0.00022	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—MTHFR—uterine cancer	5.72e-06	0.000216	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—MTHFR—uterine cancer	5.68e-06	0.000215	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.54e-06	0.00021	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PTEN—uterine cancer	5.53e-06	0.00021	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—PIK3CA—uterine cancer	5.5e-06	0.000208	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—TP53—uterine cancer	5.32e-06	0.000202	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—EP300—uterine cancer	5.28e-06	0.0002	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—PIK3CA—uterine cancer	5.24e-06	0.000198	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PTEN—uterine cancer	5.12e-06	0.000194	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—HRAS—uterine cancer	5.09e-06	0.000193	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.04e-06	0.000191	CbGpPWpGaD
Pitavastatin—UGT1A3—Metabolism—AKT1—uterine cancer	5.04e-06	0.000191	CbGpPWpGaD
Pitavastatin—ALB—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.01e-06	0.00019	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—MTHFR—uterine cancer	4.98e-06	0.000189	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—EP300—uterine cancer	4.89e-06	0.000185	CbGpPWpGaD
Pitavastatin—SLCO1B3—Metabolism—AKT1—uterine cancer	4.75e-06	0.00018	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—MTHFR—uterine cancer	4.65e-06	0.000176	CbGpPWpGaD
Pitavastatin—ALB—Hemostasis—AKT1—uterine cancer	4.49e-06	0.00017	CbGpPWpGaD
Pitavastatin—UGT2B7—Metabolism—AKT1—uterine cancer	4.28e-06	0.000162	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.1e-06	0.000155	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—PIK3CA—uterine cancer	3.9e-06	0.000148	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—PIK3CA—uterine cancer	3.62e-06	0.000137	CbGpPWpGaD
Pitavastatin—SLCO1B1—Metabolism—AKT1—uterine cancer	3.19e-06	0.000121	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PTEN—uterine cancer	3.18e-06	0.00012	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PTEN—uterine cancer	3.16e-06	0.00012	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—EP300—uterine cancer	3.03e-06	0.000115	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—EP300—uterine cancer	3.02e-06	0.000114	CbGpPWpGaD
Pitavastatin—ABCG2—Metabolism—AKT1—uterine cancer	2.95e-06	0.000112	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PTEN—uterine cancer	2.77e-06	0.000105	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—EP300—uterine cancer	2.64e-06	0.0001	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PTEN—uterine cancer	2.59e-06	9.8e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—EP300—uterine cancer	2.47e-06	9.34e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.24e-06	8.49e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—PIK3CA—uterine cancer	2.23e-06	8.45e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—PIK3CA—uterine cancer	1.95e-06	7.4e-05	CbGpPWpGaD
Pitavastatin—CYP2C8—Metabolism—AKT1—uterine cancer	1.83e-06	6.94e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.83e-06	6.91e-05	CbGpPWpGaD
Pitavastatin—ALB—Metabolism—AKT1—uterine cancer	1.82e-06	6.9e-05	CbGpPWpGaD
Pitavastatin—ABCB1—Metabolism—AKT1—uterine cancer	1.6e-06	6.04e-05	CbGpPWpGaD
Pitavastatin—CYP2C9—Metabolism—AKT1—uterine cancer	1.49e-06	5.65e-05	CbGpPWpGaD
